The $29.1 billion merger between Express Scripts Inc. (NASDAQ: ESRX) and Medco Health Solutions Inc. has been cleared by the Federal Trade Commission (FTC) and the companies have announced that the completion of the merger. The merger was allowed on a 3-1 vote of the FTC.
It appears that the FTC bought the argument from Express Scripts and Medco that the combined company would have more clout with pharmacies and drug makers to reduce prices to consumers. Critics argued that allowing the merger would reduce competition and drive up costs to consumers.
In a dissenting opinion, commissioner Julie Brill argued that no court has ever approved a merger that created a “duopoly” in a market and that the merger should have been enjoined and gone to trial in federal court. Caremark CVS Corp. (NYSE: CVS) is the other large pharmacy benefits management firm Brill referred to as part of the duopoly.
Express Scripts shares are up about 4.9% shortly after opening this morning at $56.81 in a 52-week range of $34.47-$60.89.
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
